Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Bullboard (TSX:AEZS)

View:
Comment by Tencentson Oct 18, 2024 4:31pm

RE:RE:RE:Re: Moment of Tru

In its recent PR succession plan is put in place - on march 3 2024 I opinioned this seemed to have been a big omission from the merger information documents 
Comment by tigerproon Aug 12, 2024 4:20am

RE:RE:Re: Moment of Tru

Even we know the CEO cheated the big shareholder OATS before the merge vote,    the CEO can still keeps the board position.    I can not believe this,  I dont' know which ...more  
Comment by tigerproon Aug 12, 2024 4:17am

RE:Re: Moment of Tru

I have sold my shares with big loss.     It is my fault to believe a liar CEO. Gagnon will lead the new company to bankruptcy before he steals the last money from the new company.  ...more  
Post by prophetoffactzon Aug 08, 2024 9:05pm

PGX-YBG

Based on average timeline from submission to the journal Biomaterials to publishing the comprehensive article on PGX-YBG/Fibrosis could be published within the next 30 days. In the October Small Cap ...more  
Comment by prophetoffactzon Aug 07, 2024 9:27pm

RE:H.C. Wainwright 26th Annual Global Investment Conference

I don't know if AEZS is presenting or not but... 
Post by prophetoffactzon Aug 07, 2024 9:24pm

H.C. Wainwright 26th Annual Global Investment Conference

H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024
Post by prophetoffactzon Aug 07, 2024 3:07pm

Interest rates

Bill Dudley: The Fed needs to get interest rates to a neutral setting, and that is probably 150-200 bps below where rates are presently set
Post by prophetoffactzon Aug 07, 2024 10:36am

COSCIENS Biopharma Inc

About 9 months from the announcement of the proposed merger to its completion name change and change in the symbol for the stock.  Now it looks like the new company will be launched over the ...more  
Comment by Tencentson Aug 04, 2024 3:07am

RE:Current COVID wave: Immune booster anyone?

WHO recommends for immune booster diet - vegetables/fruits exercise hydration Regular sleep moderate alcohol  reduce stress update vaccins 
Post by prophetoffactzon Aug 01, 2024 4:31pm

Biotech Bull Market: Goldman on interest rate cuts

"We now price 200bps of cuts though YE 2025, and over 75bps of cuts through the end of this year." - Goldman.
Post by prophetoffactzon Aug 01, 2024 8:54am

β-glucan particles

Recognition of yeast β-glucan particles triggers immunometabolic signaling required for trained immunity Abstract Fungal β-glucans are major drivers of trained immunity which increases long ...more  
Post by prophetoffactzon Jul 31, 2024 1:59pm

Potential synergies with the latest research

Perplexity Ai: Based on the complementary research on velocity and bioactivity, avenanthramides (AVE) and beta-glucan (BG) are likely to perform synergistically when used together, potentially ...more  
Comment by prophetoffactzon Jul 31, 2024 9:09am

RE:RE:RE:Angiogenesis Foundation Publishes Results

What these additional results were expected to achieve July 2023. That was before the merger which optimized the company to bring transformational products to market. Gilles has also talked about a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities